Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
9.90
-0.09 (-0.90%)
May 8, 2025, 4:00 PM EDT - Market closed

Theravance Biopharma Market Cap

Theravance Biopharma has a market cap or net worth of $495.01 million as of May 8, 2025. Its market cap has increased by 8.65% in one year.

Market Cap
495.01M
Enterprise Value
401.51M
1-Year Change
8.65%
Ranking
Category
Stock Price
$9.90

Market Cap Chart

Since May 16, 2014, Theravance Biopharma's market cap has decreased from $740.70M to $495.01M, a decrease of -33.17%. That is a compound annual growth rate of -3.60%.

History

DateMarket Cap% Change
May 7, 2025494.20M6.81%
Dec 31, 2024462.70M-17.33%
Dec 29, 2023559.70M-25.95%
Dec 30, 2022755.80M-7.20%
Dec 31, 2021814.40M-28.37%
Dec 31, 20201.14B-22.64%
Dec 31, 20191.47B3.64%
Dec 31, 20181.42B-6.02%
Dec 29, 20171.51B-8.88%
Dec 30, 20161.66B166.99%
Dec 31, 2015620.20M28.99%
Dec 31, 2014480.80M-35.09%
View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 674.62B
Johnson & Johnson 374.31B
UnitedHealth Group 350.97B
AbbVie 328.29B
Novo Nordisk 287.72B
Abbott Laboratories 233.17B
Novartis AG 215.89B
AstraZeneca 208.98B
Market Cap Rankings